Vortioxetine hydrobromide tablets are not recommended for children under 18 years of age.
1.Vortioxetine hydrobromide tablets are medications used to treat depression in adults.There are no data available to determine the safety and effectiveness of this medication in patients younger than 18 years of age.Therefore,it is not recommended to use this medication in children under 18 years of age.If a child is 18 years of age or older,he or she may take vortioxetine hydrobromide tablets.
2. Adverse reactions may occur after taking vortioxetine hydrobromide tablets. The most common adverse reaction is nausea, which is often mild to moderate and occurs in the first 2 weeks of taking the drug, and usually does not require discontinuation of the drug. It should be noted that this drug is contraindicated in patients who are allergic to this drug.
This drug should not be used in combination with non-selective monoamine oxidase inhibitors such as phenelzine or selective monoamine oxidase inhibitors such as moclobemide. If you need to take vortioxetine hydrobromide tablets, do so under the supervision of a physician.